Question 1

Which is bigger, ABBV or BMY?

Accepted Answer

Abbvie Inc. is the larger company — market cap $488B vs $121B for Bristol-Myers Squibb Co..

Question 2

Which is more profitable, ABBV or BMY?

Accepted Answer

BMY keeps more of each revenue dollar as profit — net margin 18.9% vs 9.8% for ABBV.

Question 3

Which stock is cheaper, ABBV or BMY?

Accepted Answer

On earnings, BMY trades at a lower P/E — 13.0 vs 77.4 for ABBV. A lower P/E means paying less per dollar of earnings.

Question 4

Which pays a higher dividend, ABBV or BMY?

Accepted Answer

BMY yields 6.28% vs 2.45% for ABBV.

Question 5

Which is the better stock — ABBV or BMY?

Accepted Answer

On reported financials, ABBV leads 5 of 12 comparable metrics and BMY leads 7. StockCV rates ABBV “Mixed” and BMY “Solid”. This is information, not investment advice — compare the full CVs before drawing conclusions.

Metric	ABBV	BMY
Price	$276.43	$59.14
Market cap	$488B	$121B
Revenue (TTM)	$64.4B	$49.2B
Revenue growth	+1.8%	+1.4%
Net margin	9.8%	18.9%
Free cash flow	$18.2B	$11.4B
Net cash (debt)	($56.2B)	($34.4B)
1-year price return	+19.8%	+32.4%
P/E	77.4	13.0
P/E vs own history (cheap-side %)	23%	90%
Dividend yield	2.45%	6.28%
Return on equity	96%	47%
Altman Z-score	2.33	2.16
CV checks passed	9 of 11	11 of 11
Employees	57,000	32,500

Abbvie Inc. vs Bristol-Myers Squibb Co.